Michael Pfenning

1.2k total citations
18 papers, 989 citations indexed

About

Michael Pfenning is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Michael Pfenning has authored 18 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Michael Pfenning's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (7 papers) and Ion channel regulation and function (5 papers). Michael Pfenning is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (7 papers) and Ion channel regulation and function (5 papers). Michael Pfenning collaborates with scholars based in United States. Michael Pfenning's co-authors include Elliott Richelson, Judith A Gilbert, Carlos Forray, R. Michael Snider, Eric W. Larson, André Terzic, C. Michel Harper, Gregory J. Gores, Shigenobu Kanba and Daniel McCormick and has published in prestigious journals such as Journal of Clinical Investigation, Brain Research and Journal of Neurochemistry.

In The Last Decade

Michael Pfenning

18 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pfenning United States 15 670 544 159 127 108 18 989
Jean‐Claude Beaujouan France 21 1.0k 1.6× 880 1.6× 196 1.2× 41 0.3× 101 0.9× 34 1.2k
Gregory N. Ervin United States 19 753 1.1× 535 1.0× 161 1.0× 43 0.3× 50 0.5× 30 1.2k
R. Markstein Switzerland 22 927 1.4× 778 1.4× 124 0.8× 58 0.5× 86 0.8× 62 1.5k
P.F.M. Janssen Belgium 13 736 1.1× 578 1.1× 129 0.8× 82 0.6× 146 1.4× 20 1.1k
D. O'Shaughnessy United Kingdom 10 438 0.7× 381 0.7× 116 0.7× 49 0.4× 78 0.7× 14 939
C. Garret France 24 1.2k 1.8× 926 1.7× 404 2.5× 51 0.4× 190 1.8× 59 1.6k
R. C. Dow United Kingdom 20 417 0.6× 200 0.4× 82 0.5× 67 0.5× 80 0.7× 33 900
Rémi Quirion Canada 18 1.4k 2.2× 908 1.7× 346 2.2× 57 0.4× 127 1.2× 25 1.7k
Isabelle Leroux‐Nicollet France 20 600 0.9× 344 0.6× 109 0.7× 73 0.6× 53 0.5× 40 1.0k
M. Conrath France 23 813 1.2× 391 0.7× 610 3.8× 357 2.8× 102 0.9× 47 1.4k

Countries citing papers authored by Michael Pfenning

Since Specialization
Citations

This map shows the geographic impact of Michael Pfenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pfenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pfenning more than expected).

Fields of papers citing papers by Michael Pfenning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pfenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pfenning. The network helps show where Michael Pfenning may publish in the future.

Co-authorship network of co-authors of Michael Pfenning

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pfenning. A scholar is included among the top collaborators of Michael Pfenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pfenning. Michael Pfenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Terzic, André, Michael Pfenning, Gregory J. Gores, & C. Michel Harper. (2015). Regenerative Medicine Build-Out. Stem Cells Translational Medicine. 4(12). 1373–1379. 44 indexed citations
2.
Terzic, André, C. Michel Harper, Gregory J. Gores, & Michael Pfenning. (2013). Regenerative Medicine Blueprint. Stem Cells and Development. 22(1_suppl). 20–24. 17 indexed citations
3.
Al-Rodhan, Nayef R. F., Elliott Richelson, Judith A Gilbert, et al.. (1991). Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Research. 557(1-2). 227–235. 78 indexed citations
4.
Larson, Eric W., Michael Pfenning, & Elliott Richelson. (1991). Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart. Psychopharmacology. 103(2). 162–165. 22 indexed citations
5.
Kanba, Shigenobu, Michael McKinney, Michael Pfenning, et al.. (1990). Desensitization of muscarinic M1 receptors of murine neuroblastoma cells (clone N1E-115) without receptor down-regulation and protein kinase C activity. Biochemical Pharmacology. 40(5). 1005–1014. 18 indexed citations
6.
Gaisano, Herbert Y., et al.. (1989). Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion.. Journal of Clinical Investigation. 83(1). 321–325. 60 indexed citations
7.
8.
Pfenning, Michael, et al.. (1986). Acute effects of ethanol and other short-chain alcohols on the guanylate cyclase system of murine neuroblastoma cells (clone N1E-115).. Journal of Pharmacology and Experimental Therapeutics. 236(2). 458–463. 15 indexed citations
9.
Richelson, Elliott, et al.. (1986). Effects of chronic exposure to ethanol on the prostaglandin E1 receptor-mediated response and binding in a murine neuroblastoma clone (N1E-115).. Journal of Pharmacology and Experimental Therapeutics. 239(3). 687–692. 35 indexed citations
10.
Snider, R. Michael, Carlos Forray, Michael Pfenning, & Elliott Richelson. (1986). Neurotensin Stimulates Inositol Phospholipid Metabolism and Calcium Mobilization in Murine Neuroblastoma Clone N1E‐115. Journal of Neurochemistry. 47(4). 1214–1218. 80 indexed citations
11.
Kanba, Shigenobu, et al.. (1986). Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin. European Journal of Pharmacology. 126(1-2). 111–116. 17 indexed citations
12.
McKinney, Michael, Michael Pfenning, & Elliott Richelson. (1986). Effect of the antitumor drug caracemide on the neurochemistry of murine neuroblastoma cells (clone N1E-115). Biochemical Pharmacology. 35(15). 2615–2622. 5 indexed citations
13.
Gilbert, Judith A, et al.. (1986). Neurotensin and its analogs—Correlation of specific binding with stimulation of cyclic GMP formation in neuroblastoma clone N1E-115. Biochemical Pharmacology. 35(3). 391–397. 50 indexed citations
14.
Pfenning, Michael, et al.. (1985). Inhibition by ethanol of forskolin-stimulated adenylate cyclase in a murine neuroblastoma clone (N1E-115). Biochemical Pharmacology. 34(20). 3655–3659. 13 indexed citations
15.
Kanba, Shigenobu, Michael Pfenning, & Elliott Richelson. (1985). Lithium ions inhibit function of lowbut not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115). Psychopharmacology. 86(4). 413–416. 20 indexed citations
16.
Gilbert, Judith A, Michael Pfenning, & Elliott Richelson. (1984). The effect of angiotensins I, II, and III on formation of cyclic GMP in murine neuroblastoma clone N1E-115. Biochemical Pharmacology. 33(15). 2527–2530. 20 indexed citations
17.
El‐Fakahany, Esam E., Michael Pfenning, & Elliott Richelson. (1984). Kinetic Effects of Terbium Ions on Muscarinic Acetylcholine Receptors of Murine Neuroblastoma Cells. Journal of Neurochemistry. 42(3). 863–869. 7 indexed citations
18.
Richelson, Elliott & Michael Pfenning. (1984). Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. European Journal of Pharmacology. 104(3-4). 277–286. 462 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Claude Beaujouan Breakdown of academic impact, for papers by Gregory N. Ervin Breakdown of academic impact, for papers by R. Markstein Breakdown of academic impact, for papers by P.F.M. Janssen Breakdown of academic impact, for papers by D. O'Shaughnessy Breakdown of academic impact, for papers by C. Garret Breakdown of academic impact, for papers by R. C. Dow Breakdown of academic impact, for papers by Rémi Quirion Breakdown of academic impact, for papers by Isabelle Leroux‐Nicollet Breakdown of academic impact, for papers by M. Conrath
Rankless by CCL
2026